Overview

Peter C. Doherty (born 15 October 1940) is an Australian scientist trained as a veterinary surgeon who became a leading researcher in immunology. He is best known for sharing the 1996 Nobel Prize in Physiology or Medicine with Rolf M. Zinkernagel for work that clarified fundamental mechanisms of the immune system.

Key discovery

The Nobel-winning research explained how cytotoxic T lymphocytes detect and kill virus-infected cells. Doherty and Zinkernagel showed that T cells recognize fragments of viral proteins only when those fragments are presented on the surface of infected cells by the body’s major histocompatibility complex (MHC). This idea of "MHC restriction" established why immune recognition depends on both the foreign peptide and the host's own MHC molecules, resolving a longstanding puzzle in cell-mediated immunity and shaping modern immunology.

Career and honors

Doherty pursued academic research and teaching in Australia and internationally and has received many awards for his scientific contributions. He has been active in science communication and policy, writing for general audiences and advising on public health matters. His name is associated with institutions focused on infection and immunity, and his work remains a touchstone in immunological research.

Impact and applications

  • Provided conceptual foundations for vaccine design and antiviral immunity.
  • Informed understanding of transplant compatibility and autoimmune disease mechanisms.
  • Guided subsequent research into antigen presentation, T cell receptors, and immunotherapy.

Notable facts

Beyond the Nobel Prize, Doherty is recognized for public engagement and for strengthening links between basic research and clinical practice. His findings continue to influence laboratory methods and medical approaches to infection, vaccination and immune-based treatments, and are frequently cited in reviews of cellular immunity and cellular immune recognition.

Summary: Peter C. Doherty combined veterinary training with immunological research to reveal how T cells selectively target infected cells through MHC-restricted recognition—an insight that remains central to modern immunology and medicine.